{"name":"Sapience Therapeutics","slug":"sapience-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxPN3pJWE5ES2szT1pwNUxtdU1CVURtZG14LW5VcmJwRENYVmR6OFZnNlpHSTZxczQ1TG1WM1JEb1JxaEJROXk0T2NtQXJrOW5Gb1RKRUZkUmxsMkJOaGwxbUFjM1VfaTZSNC1jV0ZrOHZJTzN3S283czNnMHNXVFBWUVB3VU1SQmVpX09XMlpiLXJNUW5hdUtQRHlWaw?oc=5","date":"2026-03-25","type":"trial","source":"openPR.com","summary":"Metastatic Hepatocellular Carcinoma Clinical Trial Pipeline - openPR.com","headline":"Metastatic Hepatocellular Carcinoma Clinical Trial Pipeline","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiigJBVV95cUxOTWR5TEZScWh3MzZDb21CdmdVZUtBdGdENGxOZURFWE9VbUFBU0VxVWpPQm12NDhkam82c3hIMEJFQlJNbWFQMkRiR29TdXBuMzJOUjNjZTdCWjhrb3VzZEE3WjNyMFdqOHdhSGhNZmd2aks5Q0t5OWY5bmYyWVk3NWNtcVN6VTNkVUJxYjQ3Zy1BempJQmkzWlNwT1lScW1EQmhiRVJoVzV0am5FNzNnc1dfMGFaTGNWRnlpdEZZUXZKTnlhWjQyc0VpRC1XZzRTNDlIMUkwZS1tX3FGNWRfMFFmcHBVaEV5dndLb0FEcDJLYncwdGNMbjhhUXZQdk1PU1hoRzRwUGx5Zw?oc=5","date":"2026-03-18","type":"pipeline","source":"PR Newswire","summary":"Sapience Therapeutics to Present Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2026 - PR Newswire","headline":"Sapience Therapeutics to Present Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting ","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-12","type":"pipeline","source":"GlobeNewswire","summary":"Peptide Therapeutics Market Trends and Global Forecasts to - GlobeNewswire","headline":"Peptide Therapeutics Market Trends and Global Forecasts to","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTFB1NjF5MmRZM3N4ZDFodDM0UVV6MmwwZk9CWXdaVjk5Uy1BTnBTVEwxeFFlMGdSeU95bld1ZkpSM2FKX0xtcXRmYUtTZVNXa3hDdlJxdEJQWHpYWGlj?oc=5","date":"2025-11-14","type":"trial","source":"EurekAlert!","summary":"New study reveals how brain fluid flow predicts survival in glioblastoma - EurekAlert!","headline":"New study reveals how brain fluid flow predicts survival in glioblastoma - EurekAlert!","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxPeUVrUU1VX0VvWW9QMzJVSlJrZTVIUjB1eThMT3NHX2VzempVTUlJZy1RUEFaWl9HMHU1eU1xRjRtRHVyT0lqQXBxTmNSWDNselJfZmkwVXYwSExmdDUxTEhsOTNCdXk2ZUV0SGhyWFlZSWFEZ2pYQ0xBRXFDcTBOS2UwMkcxV05Ub2tBWnBrdGwwWXRna2RqOFphRjIzTzFYdWZhY2FKQ0NiZXh5V2R5Q3cwZDB3SnJGVS1MVWtB?oc=5","date":"2025-10-09","type":"pipeline","source":"Seeking Alpha","summary":"Recursion Pharmaceuticals: Recent Gains Mysterious Given Lack Of Overall Progress (RXRX) - Seeking Alpha","headline":"Recursion Pharmaceuticals: Recent Gains Mysterious Given Lack Of Overall Progress (RXRX)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gJBVV95cUxPa3M3djA4eTRhTk0xYndSTWIzTHN1ZllqUnBaaGtzbkUzeU9MMk13UFZXZHpIZUVEQlR3OHNVeWQ3SFRyYmc0VU1Ed0xvVC1ZZ2gyRzJxUHJvTUZzeFJQei1NdGFrek9wajl4blB5NUl5dUc1RkZNYW5GMlVhZ0pTXzZZVE5tZjZQd2dHSXJoX3ZXZjlaQXFGcXNya195dm1xZXFFdTJuUzdjOXRUOWdZOVJKa0NIQlNXYVVLM0Fhdk5lWWgxVjV0eEhySHdWRkN6bHdqTlhENXJkbUw1a2dvREgzeGJhQ2VYM0hyMnBqUFZ1eXFJaEJMY21sWU14VVdicFcxbXJRQWt1SnJBTVFpbTc1a3BscnlUeGRWQW8zMEZHbFU3U2tDWUNNRzFsTERfUGxCRzhsTEFPakFoTWZZWWJvcVhmcXNpRUtPbEpDRnZNQQ?oc=5","date":"2025-06-02","type":"trial","source":"PR Newswire","summary":"Sapience Therapeutics Provides Data Update from Phase 2 Trial of Lucicebtide in Patients with Glioblastoma at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting - PR Newswire","headline":"Sapience Therapeutics Provides Data Update from Phase 2 Trial of Lucicebtide in Patients with Glioblastoma at the 2025 A","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxOQmZNRzEwZG1iYUd6ajVzY3VvR1p3eWt3R182LU5kU2xIRzRZWEtiODg4V0xWZVk1RHVlY0NxeG9Tb1cxN1VZRUpjejJYdmtuXzBGYkYwVG53SzF1N1BGRzA3SEhfMk5fQjB1bWlDOS1mNDNURkFIeGtCdXY2TXhodVdXNkE4OFRiVWV4TGF0TFF5bm9zazRVTFV2dURTeHFma3IzVExONW9HczkyLXpvR3dvVk9KVU5lN2JvSFZ5ZmwyQ2pqTFB5YU0yWno0cXRZUVV6WGtYR293a0xDc0dRaQ?oc=5","date":"2025-05-27","type":"pipeline","source":"PR Newswire","summary":"Sapience Therapeutics Announces Participation in the Jefferies Global Healthcare Conference - PR Newswire","headline":"Sapience Therapeutics Announces Participation in the Jefferies Global Healthcare Conference","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxPZW9IczI4elJIR2VqeXFxbFpXb0s2aEhpQUh2RHBJM0U2engzam51N1pDOWtpM0lHbDh5YWNlUmExczdiWGlCcXczY09GazFLTkotTEVsaWZ6MU00c2ZEVXcwaUtZNWxsOXc3NVhaVzhkYlB2dkQ0WFA4R3JTOG85OXIzOVlWaVJ3WUZMR3JZRFFZRmRGR1JqM0pkMmkwTGVy?oc=5","date":"2024-05-20","type":"pipeline","source":"Business of Cannabis","summary":"Ex-GW Pharma Bosses Lead Development of New CBD-Based Epilepsy Drug - Business of Cannabis","headline":"Ex-GW Pharma Bosses Lead Development of New CBD-Based Epilepsy Drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAJBVV95cUxNNzZqNzZ0WEMzZmtKREZqYkVteEtLMW9LOHRKWndNaHlMWTcwVmRsbG1vUU56ZzRIbDlQR0lnbXRnd3Fzb2xCcFc1OEY1U1pOVWxIMmtLRHlWSmwtNEJLclR5NXZyUldCWUk4NjZuaHFMVkxZUUV6VzZ0VXhpc1JtSURNaWNRblJRQ090ZWc2RTkzLUpYeXJmTjhxNmdrVzZnUFgwWUQ2d0c1MHFmemw5RlF1cERVa28tYm9VcFRMSDdzaGNqYXdMRTVIeFN2ZDJFamdJZXlPLXFTLUQzLUpzUEV5ekctdlJHQnpVckI3NkFKODVPTTdnN1pqcGQ1QTQ4?oc=5","date":"2024-05-13","type":"pipeline","source":"Business Wire","summary":"Avata Biosciences Emerges to Develop Solid Dose Cannabinoid Medicines for Epilepsy and Other Neurological Diseases - Business Wire","headline":"Avata Biosciences Emerges to Develop Solid Dose Cannabinoid Medicines for Epilepsy and Other Neurological Diseases","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxPNU0zUUNhSUhScHlrbURxZGhsVnhnRmNMVHdLVlFYcWk4eVVwaTlFQ3EtX2k2QXk0MmdMaE5MYWp2SFdLbDZGWG5PNFdia01WWVdNZFFZdF9KRGxjOXVhQ2ktbGEyeENpQ09QUVNrcU5CRHdRYm1BV0lCV19ZbDZMemUyZUFFS1RWRUpudE1KektrQmFFVXVLSGRKOGEySGdWOTNQd1dicG81Tkttb1BRbEM5Zkw3S1VxSWlyUy0wZG9rclpWLTRrYUppWHpuNUFrRU5SbXdSXzMtNTJlZE5xSnc3ek4tQV9oSHZTMktESVRXMXJsOVE?oc=5","date":"2023-12-19","type":"trial","source":"Business Wire","summary":"Sapient Therapeutics Announces Positive Phase 1 Results in Part B of Its Solid Dose Prescription CBD Study - Business Wire","headline":"Sapient Therapeutics Announces Positive Phase 1 Results in Part B of Its Solid Dose Prescription CBD Study","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiT0FVX3lxTFBxYUVwUFlyc2N0amt1UWZ2XzJoUzFGYTBkUXdIaVNjWTg3NkdQUW5zOF9xeEl4RV9LRE5QUnpucTAyejNfeHZCR0NJeEI1cFk?oc=5","date":"2017-05-18","type":"pipeline","source":"nature.com","summary":"Therapeutic developments: Masters of medicine - nature.com","headline":"Therapeutic developments: Masters of medicine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPY19FWTFMSDk5U3ZULWNRdUpsbW1xOXQxaW45VlNVdlRfS0lZY0s1THpiX3hhdUFOekJxNEM3ZVNPUllZSGlVNG1TeVE1aHEyaFNqT0k5RnNyRUZSSjVzYkV1dURBcVJaX1ROTGVBSFh4aGVMRy1hR2t1ZUtGUks2UXlxeklUMFBpY3NFLVJuS2lkcGZBS0RZZXdJMnhvY2ZtZlZHMGV3?oc=5","date":"2016-07-12","type":"pipeline","source":"Fierce Biotech","summary":"Upstart Sapience raises $22.5M in Series A, with help from Celgene - Fierce Biotech","headline":"Upstart Sapience raises $22.5M in Series A, with help from Celgene","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}